Skeletal metastases in advanced prostate cancer: cell biology and therapy.
Koutsilieris
M
M
Molecular Endocrinology Laboratory, Centre Hospitalier, L'Universite Laval (C.H.U.L), Ste. Foy, Quebec, Canada.
D000230:Adenocarcinoma / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D000328:Adult; D000726:Androgen Antagonists / Q000627:therapeutic use; D000818:Animals; D001859:Bone Neoplasms / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D003131:Combined Modality Therapy; D004164:Diphosphonates / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D008297:Male; D008934:Mitogens / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D009376:Neoplasms, Hormone-Dependent / Q000556:secondary / Q000628:therapy; D009919:Orchiectomy; D010006:Osteoblasts / Q000473:pathology; D010166:Palliative Care; D011471:Prostatic Neoplasms / Q000378:metabolism / Q000473:pathology*; D051381:Rats; D011919:Rats, Inbred Strains
D000726:Androgen Antagonists; D004164:Diphosphonates; D005938:Glucocorticoids; D006133:Growth Substances; D008934:Mitogens; D009363:Neoplasm Proteins; D007987:Gonadotropin-Releasing Hormone